`

AVROBIO

Biotechnology Research

Specialities :
Gene therapy and rare disease
revenue-icon Revenue
11M - 100M
funding-icon Total Funding
$60.0M
size-icon Size
11 - 50

Frequently Asked Questions About AVROBIO

What does Avrobio do?+

Our vision is to bring personalized gene therapy to the world. We target the root cause of genetic disease by introducing a functional copy of the affected gene into patients own hematopoietic stem cells (HSCs), with the goal of durably expressing the therapeutic protein throughout the body, including the central nervous system. Our first-in-class pipeline includes clinical programs for Gaucher disease and Hunter syndrome, as well as a preclinical program for Pompe disease. Our proprietary plato gene therapy platform is scalable for planned global commercialization. We are headquartered in Cambridge, Mass. For additional information, visit avrobio.com, and follow us on...

What are Avrobio's specialties? +

Gene therapy and rare disease

What is Avrobio's industry? +

Avrobio operates in the Biotechnology research industry.

What is Avrobio's revenue? +

Avrobio's revenue is 11m - 100m

What is Avrobio's company size? +

Avrobio has 11 - 50 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.